Phase 1 study showed significant lung uptake and enhanced epithelial lining fluid (ELF) and alveolar macrophage (AM) ...

University of Galway will lead a new research project aimed at understanding the development of neurodegenerative diseases.

Darier disease (DD) is a rare cutaneous disease caused by heterozygous mutations in the ATP2A2 gene, which encodes sarco/endoplasmic reticulum calcium ATPase isoform 2 (SERCA2).

Propranolol reduces experimental murine cerebral cavernous malformations (CCMs) and prevents embryonic caudal venous plexus (CVP) lesions in zebrafish that follow mosaic inactivation of ccm2. Because ...

Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting ...

New Istaroxime Phase 2b clinical results to be presented by Windtree and top cardiology expert Review of cardiogenic shock and other programs, including Windtree’s strategy and planned near-term ...

So he hired himself out anonymously to a lady in another expensive neighborhood who did have garden space, telling her that ...

This study is led by Prof. Cai-Ping Tan, Prof. Zong-Wan Mao (MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, ...

A research team identified Ru5 as a potent antitumor agent by screening a panel of ruthenium(II) polypyridine complexes ...

宾夕法尼亚州WARRINGTON - 生物技术公司Windtree Therapeutics, Inc. (NASDAQ:WINT)今天宣布,其istaroxime药物的2b期SEISMiC延伸研究达到了主要终点,在6小时内显著改善了由心力衰竭引起的早期心源性休克患者的收缩压。该研究还报告了有利的次要结果和一致的安全性特征。 SEISMiC延伸研究覆盖美国、欧洲和拉丁美洲,重点研究istaroxi ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Foghorn Therapeutics (FHTX – Research Report) yesterday and set a price ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, presented new data on Friday highlighting the impact of alterations in FBXW7, ...